Potential of statins for the treatment of multiple sclerosis.
Baker
David
D
Neuroinflammation Group, Institute of Neurology, University College London, UK.
Adamson
Peter
P
Greenwood
John
J
D000276:Adjuvants, Immunologic / Q000494:pharmacology; D001327:Autoimmune Diseases / Q000188:drug therapy / Q000517:prevention & control; D002490:Central Nervous System / Q000473:pathology; D004681:Encephalomyelitis, Autoimmune, Experimental / Q000188:drug therapy / Q000517:prevention & control; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use*; D007962:Leukocytes / Q000187:drug effects; D009103:Multiple Sclerosis / Q000188:drug therapy* / Q000473:pathology
D000276:Adjuvants, Immunologic; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors